Tags

Type your tag names separated by a space and hit enter

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
J Clin Gastroenterol. 2008 Sep; 42 Suppl 3 Pt 1:S123-5.JC

Abstract

To review the rationale and current evidence for the efficacy of probiotics in the treatment of irritable bowel syndrome (IBS), the following specific questions are addressed from a review of the published literature: Are bacterial flora altered in IBS? Is infection a significant risk factor for IBS? How prominent is the inflammation in IBS? Do probiotics change bacterial flora? Do probiotics adhere to mucosa? What are the potential mechanisms of action of probiotics in IBS: immune function, motor, secretory, sensory, and fermentation? What is the efficacy of probiotics in IBS?

Authors+Show Affiliations

Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA. camilleri.michael@mayo.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18806702

Citation

Camilleri, Michael. "Probiotics and Irritable Bowel Syndrome: Rationale, Mechanisms, and Efficacy." Journal of Clinical Gastroenterology, vol. 42 Suppl 3 Pt 1, 2008, pp. S123-5.
Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 1:S123-5.
Camilleri, M. (2008). Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. Journal of Clinical Gastroenterology, 42 Suppl 3 Pt 1, S123-5. https://doi.org/10.1097/MCG.0b013e3181574393
Camilleri M. Probiotics and Irritable Bowel Syndrome: Rationale, Mechanisms, and Efficacy. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 1:S123-5. PubMed PMID: 18806702.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. A1 - Camilleri,Michael, PY - 2008/10/1/pubmed PY - 2008/12/17/medline PY - 2008/10/1/entrez SP - S123 EP - 5 JF - Journal of clinical gastroenterology JO - J Clin Gastroenterol VL - 42 Suppl 3 Pt 1 N2 - To review the rationale and current evidence for the efficacy of probiotics in the treatment of irritable bowel syndrome (IBS), the following specific questions are addressed from a review of the published literature: Are bacterial flora altered in IBS? Is infection a significant risk factor for IBS? How prominent is the inflammation in IBS? Do probiotics change bacterial flora? Do probiotics adhere to mucosa? What are the potential mechanisms of action of probiotics in IBS: immune function, motor, secretory, sensory, and fermentation? What is the efficacy of probiotics in IBS? SN - 1539-2031 UR - https://www.unboundmedicine.com/medline/citation/18806702/Probiotics_and_irritable_bowel_syndrome:_rationale_mechanisms_and_efficacy_ L2 - https://doi.org/10.1097/MCG.0b013e3181574393 DB - PRIME DP - Unbound Medicine ER -